What is Milrinon?

Milrinon is a medicine used to help people who experience sudden heart failure. Heart failure occurs when the heart is unable to pump blood for the rest of the body. Milrinone can be used orally, injected or administered through an intravenous line (IV). It is the most commonly used phosphodiesterase-III inhibitor, a type of drug that helps the heart contract and at the same time relaxes and expands the blood vessels.

This medicine is usually given in a medical office or in a hospital environment and is not recommended to be used for more than 48 hours. Milrinone patient should undergo laboratory tests to measure organs, electrolyte and blood pressure. It should also receive continuous monitoring via electrocardiogram. The drug should not be used in patients who have a serious blockage of arteries or certain heart valve problems or who have recently experienced a heart attack. It should be used with extreme caution in Children and avoids women who are pregnant or breastfeeding.Other serious side effects requiring immediate attention include severe allergic reaction, chest pain, severe dizziness, bronchospasm and low potassium levels. Common side effects include dizziness, headaches, tremor and easy bruises or bleeding.

The use of Milrinon has created controversy in the medical world. It has been shown that they receive increased mortality among patients who receive a large amount of millrinon in their oral form. Milrinon is usually not recommended for long -term use in people with congestive heart failure. In the form of IV, Milrinon can be combined with beta-blockers therapy, and other treatment used to improve hearing is the ability to pump. Such a combination has a synergistic effect and offers people with advanced congestive heart failures who do not have other treatment options.